Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju
Avtorji:Oblak, Irena (Avtor)
Jezik:Slovenski jezik
Tipologija:1.08 - Objavljeni znanstveni prispevek na konferenci
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Ključne besede:bolniki, rak debelega črevesa, rak danke, rak prebavil
Leto izida:2013
UDK:616.3-006
ISSN pri članku:1408-1741
OceCobissID:1553275 Povezava se odpre v novem oknu
URN:URN:NBN:SI:doc-MMKGNA7W
COBISS_ID:1554811 Povezava se odpre v novem oknu
Število ogledov:1240
Število prenosov:252
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (311,87 KB)
 
Nadgradivo:Šola tumorjev prebavil, Ljubljana, 30. 11. 2012
Onkološki inštitut
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:by Authors
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:31.08.2018

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Follow-up of colorectal cancer patients after radical treatment
Povzetek:After completed treatment, either surgical or combined treatment of colorectal carcinoma, it is necessary to follow up patients regularly and in accordance with the recommended protocol. The purpose of such follow-up is to detect the disease or its recurrence as early as possible, including pre-cancerous lesions or potential metachronous (newly developed) tumours which can be treated successfully at an early stage. Follow-up is important also for the treatment of late complications, it enables psychological support to the patients, and finally, we can also track and assess our own performance. It is known that colorectal cancer recurs in 30 do 50% of patients. As many as 70% of recurrences are detected within the first two years, 80% in the first three years, and 90% or more disease recurrences are found within five years after surgery of the primary tumour. It has been shown that regular follow-up of patients after their treatment improves the outcome of their disease and reduces mortality in patients by 9% to 13%. We must adapt it to each patient separately, taking into account both his age and general condition, stage of the disease, concurrent diseases, and further treatment possibilities in the event of a recurrence.

Arhiv

niGradiv

Nazaj